2002
DOI: 10.1016/s0928-0987(01)00195-6
|View full text |Cite
|
Sign up to set email alerts
|

In vitro simulation of food effect on dissolution of deramciclane film-coated tablets and correlation with in vivo data in healthy volunteers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2003
2003
2021
2021

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 22 publications
0
5
0
Order By: Relevance
“…Five hundred milliliters of complex solution with a pH value of 1.2 was prepared by adding 0.35 g sodium chloride, 0.5 g glycine and 31.6 mL hydrochloric solution of 1 M into distilled water [35]. A given amount of metal salt such as Pb(NO 3 ) 2 , Cu(NO 3 ) 2 or Cd(NO 3 ) 2 , was added into the solution prior to adsorption tests.…”
Section: Materials and Chemicalsmentioning
confidence: 99%
“…Five hundred milliliters of complex solution with a pH value of 1.2 was prepared by adding 0.35 g sodium chloride, 0.5 g glycine and 31.6 mL hydrochloric solution of 1 M into distilled water [35]. A given amount of metal salt such as Pb(NO 3 ) 2 , Cu(NO 3 ) 2 or Cd(NO 3 ) 2 , was added into the solution prior to adsorption tests.…”
Section: Materials and Chemicalsmentioning
confidence: 99%
“…For extended release formulations, reasonable linear correlations have been obtained from a number of IVIVC studies [1,2,3,4,5]. In other cases, linear correlations were not satisfactory [6,7,8,9], or the data could not be correlated [2,10,11]. Although in the case of extended release formulations linear relationships are frequently obtained, both the United States Pharmacopoeia (USP) and the Food and Drug Administration (FDA) state that non-linear models are also acceptable to describe IVIVCs [12,13,14].…”
Section: Introductionmentioning
confidence: 99%
“…In vitro–in vivo correlations (IVIVCs) are correlations between in vitro dissolution data and in vivo release kinetics, estimated by the deconvolution of pharmacokinetic IVIVCs were constantly recommended by regulatory authorities in the last decades when developing extended-release formulations ( US Food and Drug Administration, 1997a ; US Food and Drug Administration, 1997b ; European Medicines Agency, 2014a ; European Medicines Agency, 2014b ). The correlation can be good and even linear ( Humbert et al, 1994 ; Eddington et al, 1998 ; Emami 2006 ) or nonlinear [ Lake et al, 1999 ; Varshosaz et al, 2000 ; Rao et al, 2001 ; Al-Behaisi et al, 2002 ], or even obscure ( Eddington et al, 1998 ; Mircioiu et al, 2005 ; Meyer et al, 1998 ; Mircioiu et al, 2018 ). Complex models were proposed in cases of nonlinearity ( Polli et al, 1996 ; Dunne et al, 1997 ; Dunne et al, 1999 ), but the number of parameters of models is higher, and the fitting algorithms are more unstable ( Sandulovici et al, 2009 ; Tvrdonova et al, 2009 ).…”
Section: Introductionmentioning
confidence: 99%